Attend Our Live Webinar!

In this webinar, industry expert Leora Horn will share how Astrazeneca is using multimodal data to aid in the design of all Phase 3 studies across the oncology portfolio, which resulted in an overall increase in PTS by 5 percentage points per study. She will also discuss the use of real-world data to select the right patient populations to enroll in studies and inform study design and stratification factors.

Register for this webinar to learn more.